JMP Resumes PBM Providers: CVS, MCK, ESRX at Outperform, CTRX at Market Perform

Article Stock Quotes (8) Comments (0)

An analyst at JMP Securities resumed coverage on several stocks in the Pharmacy Benefit Management group Tuesday morning:

• CVS (NYSE: CVS) with a Market Outperform rating and $55 price target
  
• McKesson (NYSE: MCK) with a Market Outperform rating and $107 price target
  
• Express Scripts (Nasdaq: ESRX) with a Market Outperform rating and $66 price target
  
• Catamaran (Nasdaq: CTRX) (formerly SXC Health Solutions) with a Market Perform rating and $112 price target

Check out our Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Topeka Capital Starts Laredo Petroleum (LPI) at Buy, Assets 'Undervalued'
• Topeka Capital Starts Precision Castparts (PCP) at Buy
• BTIG Starts Ambac Financial (AMBC) at Buy, Interesting Play with 'Optionality'

Create E-mail Alert Related Categories

New Coverage

Related Entities

JMP Securities

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?